- Home
- Products
CIDOFOVIR (Visitide)
CIDOFOVIR (Visitide)
- Medicine Name: VISTIDE
- Generic Name: Cidofovir
- Dosage Form & Strength: Injection – 375 mg/5 mL vial (single-unit carton)
- Manufactured By: Gilead Sciences, Inc.
- FDA Approval Date: Yes (Approved June 1996)
VISTIDE (Cidofovir) is an antiviral medication used for the treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS). It is not intended for other viral infections.
Recommended Dosage:
- Induction Phase: 5 mg/kg via intravenous infusion over 1 hour, once a week for two consecutive weeks
- Maintenance Phase: Starting two weeks after induction, 5 mg/kg IV infusion every two weeks
Vistide must be co-administered with probenecid and intravenous hydration to minimize kidney toxicity.
Nephrotoxicity: Serious risk of kidney damage. Monitor renal function closely and ensure hydration and use of probenecid.
Contraindicated in Renal Impairment: Do not use in patients with pre-existing renal dysfunction.
Hematologic Toxicity: Monitor complete blood counts regularly for neutropenia and anemia.
Ocular Effects: May reduce intraocular pressure; monitor for ocular hypotony.
Metabolic Acidosis: Monitor bicarbonate and metabolic parameters.
Eye Inflammation: Risk of uveitis and iritis—monitor for symptoms.
Pregnancy Risk (Category C): May harm the fetus. Avoid use during pregnancy.
Breastfeeding: Not recommended due to potential risk to infants.
Required Documents for Import to India:
- Valid doctor’s prescription
- Patient’s diagnostic reports
- Government-issued ID proof
- Import permit, if applicable
Availability:
VISTIDE is not registered in India but may be legally imported for personal use under Named Patient Import regulations. Delivery can be arranged to cities such as Mumbai, Delhi, Bangalore, Chennai, Hyderabad, Pune, and others across India and the SAARC region.
Global Rare Meds facilitates the legal sourcing and delivery of VISTIDE (Cidofovir 375 mg/5 mL) from approved international suppliers in the USA, Canada, Europe, and Australia.
- Dispensed from our Ambernath, Thane District fulfillment center
- Processed by licensed pharmacists
- Delivered safely to Indian and international addresses following compliance protocols
We ensure genuine medications, end-to-end transparency, and prompt delivery worldwide.
What is the generic name of VISTIDE?
Cidofovir
Who manufactures VISTIDE?
Gilead Sciences, Inc.
What is VISTIDE used for?
For the treatment of cytomegalovirus (CMV) retinitis in patients with AIDS.
What is the form and strength of Cidofovir?
375 mg/5 mL solution for IV infusion, supplied in a single-use vial.
What are the common side effects?
Chills, nephrotoxicity, neutropenia, nausea, metabolic acidosis, rash, headache, and ocular inflammation.
Is there a generic available?
Yes, Cidnavir is a generic brand of Cidofovir available from licensed Indian exporters.
How can I get VISTIDE or
Cidnavir in India?
With a valid prescription, Global Rare Meds can facilitate import and delivery across India.
What is the price of VISTIDE in India?
Prices vary. To check the current price:
Phone: +91-99675 15602
WhatsApp: +91-99675 15602
Email: info@globalraremeds.com
Can it be shipped to other countries?
Yes, Global Rare Meds supports export to SAARC countries and international destinations, subject to import regulations.
What are the storage conditions for VISTIDE?
Store at 20°C to 25°C (68°F to 77°F). Protect from excessive heat or freezing.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
